← All Cargo Therapeutics, INC filings

Cargo Therapeutics, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

CRGX
Cargo Therapeutics, INC
10-K: CARGO Therapeutics Announces 2024 Financial Results and Provides Business Update
CARGO Therapeutics reports its 2024 financial results, highlighting progress in its clinical programs and strategic adjustments.
CRGX
Cargo Therapeutics, INC
10-K: CARGO Therapeutics Files 10-K, Highlights Progress in Cell Therapy Development
CARGO Therapeutics' 10-K filing details its clinical-stage progress in developing next-generation cell therapies for cancer, particularly focusing on its lead program CRG-022.